Ferozsons Laboratories Limited (KASE: FEROZ)
Health Care · Pharmaceuticals · PK
PKRs356.73
-4.79% today · -15.4% 1Y
Ferozsons Laboratories Limited (KASE: FEROZ) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $55.90M.
Over the last twelve months the share price has lost 15.4%, trading between 293.01 and 475.00.
Tweenvest scores Ferozsons Laboratories Limited across four factors: quality 60/100, value 61/100, growth 84/100, dividend 58/100. Its strongest factor is growth.
FEROZ price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $55.90M
- Revenue (TTM)
- $81.29M
- P/E
- 16.47
- EPS
- 21.66
- Dividend yield
- 1.12%
- Beta (5Y)
- 0.60
- 52-week high
- PKRs475.00
- 52-week low
- PKRs293.01
- Avg volume (3M)
- —
- Shares outstanding
- 43.47M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.06T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $650.67B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $377.72B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $365.10B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $300.07B | CHF127.18 | -0.90% |
| AstraZeneca PLCLSE: AZN | $257.89B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $210.23B | Dkr304.95 | -0.93% |
| Pfizer Inc.NYSE: PFE | $161.30B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.